STOX1 and central nervous system cancer: Considering both glioma types and GB alone, patients with high-level STOX1 expression had a significantly higher OS than those with low-level STOX1 expression did, after analysis of both the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) datasets (Figure 4a–d).